In Capitol Hill hearings, lawmakers criticize drug manufacturers for failing to fully disclose data on the use of antidepressants by children, creating a misleading impression of the drugs' safety and effectiveness. The FDA is also faulted for being too passive a regulator. Hear NPR's Snigdha Prakash.
Copyright 2004 NPR
